About

Podcasts

AxSpA Podcast: Efficacy and Safety of IV secukinumab

Podcasts

Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy

Podcasts

Author Interview: Derin Karacabeyli, 2024

Podcasts

Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases

Podcasts

PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA

Podcasts

Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials

Podcasts

Discussing AxSpA: Incidence of uveitis following bimekizumab treatment

Podcasts

Author Interview: Professor Laura Andreoli, 2024

Podcasts

Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib

Podcasts

Author Interview: Dr Adam Goldman, 2024

Podcasts

Author Interview: Professor Daniel Blockmans, 2024

Podcasts

Discussing PsA: Guselkumab and analysis of genetic markers

Podcasts

Discussing RA: July 2024

Podcasts

Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status

Podcasts

Discussing RA: June 2024

Podcasts

Discussing RA: May 2024

Podcasts

Discussing PsA: Bimekizumab therapy in PsA

Podcasts

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

Podcasts

IMID Author Interview: Dorthe Berthelsen, 2024

Podcasts

Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar

Podcasts

IMID Author Interview: Dr Jake Weddell, 2024

Podcasts

IMID Author Interview: Professor Frank Verhoeven, 2024

Podcasts

Discussing AxSpA: Long-term etanercept response and real-world effectiveness of tofacitinib and adalimumab

Podcasts

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Podcasts

Discussing RA: April 2024

Podcasts

Author Interview: Professor Maria Antonietta D’Agostino, 2024

Podcasts

Author Interview: Professor Dennis McGonagle, 2024

Podcasts

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Podcasts

Author Interview: Dr Jürgen Rech, 2024

Podcasts

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Podcasts

Discussing RA: March 2024

Podcasts

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment